Inventor · disambiguated record
Christopher R. Rovaldi
Also filed as: ROVALDI CHRISTOPHER · ROVALDI CHRISTOPHER R · ROVALDI CHRISTOPHER ROBERT
4 granted patents·10 pending applications·23 citations·filing 2015–2025
68Inventor score
Top patents by PatentIndex Score
14 records- 0194US10189882B2Methods for treating myelodysplastic syndromes and sideroblastic anemiasACCELERON PHARMA INC·Filed 2015·Granted Jan 29, 2019·21 cites·25 claims
- 0273US11471510B2Activin-ActRII antagonists and uses for treating anemiaCELGENE CORP·Filed 2015·Granted Oct 18, 2022·2 cites·20 claims
- 0369US10829531B2Methods for treating myelodysplastic syndromes and sideroblastic anemiasACCELERON PHARMA INC·Filed 2018·Granted Nov 10, 2020·0 cites·29 claims
- 0465US2021230239A1Methods for treating myelodysplastic syndromes and sideroblastic anemiasACCELERON PHARMA INC·Filed 2020·Application pending·0 cites
- 0561US2024252631A1Methods of using activin receptor type ii signaling inhibitorsKEROS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0661US2023348565A1Methods of using activin receptor type ii variantsKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0758US2024218061A1Methods of using activin receptor type ii signaling inhibitorsKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0857US2023372390A1Methods of treating lymphopeniaKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0957US2023398118A1Methods of treating cardiovascular-related diseaseKEROS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1055US12458693B2Methods of treating iron overload with a BMP inhibitorKEROS THERAPEUTICS INC·Filed 2023·Granted Nov 4, 2025·0 cites·15 claims
- 1155US2025034148A1Methods of using alk2 inhibitorsKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1254US2023142386A1Activin-actrii antagonists and uses for treating anemiaCELGENE CORP·Filed 2022·Application pending·0 cites
- 1352US2024228583A1Activin receptor type ii chimeras and methods of use thereofKEROS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1448US2025188148A1Methods of administering an activin receptor type iib variantKEROS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →